Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Current Pharmaceutical Design|April 8, 2003
Structure-based design approaches to cell wall biosynthesis inhibitorsAlan H Katz, Craig E CaufieldProteins|September 30, 2009
Modeling G protein-coupled receptors for structure-based drug discovery using low-frequency normal modes for refinement of homology models: application to H3 antagonistsBrajesh K Rai, Gregory J Tawa, Alan H Katz, et al.Journal of Pharmacological and Toxicological Methods|September 23, 2006
Use of a murine cell line for identification of human nitric oxide synthase inhibitorsSaule Naureckiene, Wade Edris, Seena K Ajit, et al.Journal of Medicinal Chemistry|September 29, 2006
Pyrazolidine-3,5-diones and 5-hydroxy-1H-pyrazol-3(2H)-ones, inhibitors of UDP-N-acetylenolpyruvyl glucosamine reductaseAdam M Gilbert, Amedeo Failli, Jay Shumsky, et al.Bioorganic & Medicinal Chemistry Letters|May 3, 2005
4-Alkyl and 4,4'-dialkyl 1,2-bis(4-chlorophenyl)pyrazolidine-3,5-dione derivatives as new inhibitors of bacterial cell wall biosynthesisKristina M K Kutterer, Jamie M Davis, Guy Singh, et al.Bioorganic & Medicinal Chemistry|August 6, 2005
Identification and characterization of small molecule modulators of KChIP/Kv4 functionMark R Bowlby, Pranab Chanda, Wade Edris, et al.Bioorganic & Medicinal Chemistry Letters|December 20, 2003
Phenyl thiazolyl urea and carbamate derivatives as new inhibitors of bacterial cell-wall biosynthesisGerardo D Francisco, Zhong Li, J Donald Albright, et al.Neuron|February 26, 2004
Two N-terminal domains of Kv4 K(+) channels regulate binding to and modulation by KChIP1Robert H Scannevin, KeWei Wang, Flora Jow, et al.Pageof 1